Navigation Links
Dr. Peter J. Pronovost to Join the Board of Directors of Cantel Medical Corp.
Date:1/13/2011

LITTLE FALLS, N.J., Jan. 13, 2011 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMN) today announced the election of Peter J. Pronovost, M.D., Ph.D. to serve as an independent member of Cantel's Board of Directors.

"Dr. Pronovost is a world renowned leader of patient safety and quality, serving as a practicing anesthesiologist and critical care physician, professor, researcher, lecturer and international patient safety leader," said Charles M. Diker, Chairman of Cantel. "His wealth of experience in the fields of patient safety, ICU and health care, evidence-based medicine, and the measurement and evaluation of safety efforts and procedures will be invaluable support and guidance for Cantel in its continuing efforts to promote and lead in infection prevention and control products and services."

Dr. Pronovost serves as a Professor in the Johns Hopkins University School of Medicine (Departments of Anesthesiology and Critical Care Medicine), in the Bloomberg School of Public Health (Department of Health Policy and Management) and in the School of Nursing. Dr. Pronovost has lectured and authored approximately 350 articles and chapters in the fields of patient safety, ICU care, quality health care, evidence-based medicine, and the measurement and evaluation of safety efforts.

For his pioneering work in patient safety and infection prevention, Dr. Pronovost was honored by being named in 2008 to Time Magazine's Time 100, which was the 5th annual list of the world's 100 most influential people: leaders, thinkers, heroes, artists, scientists, and more. Alarmed at the increasing trend in hospital-acquired infections in patients at Johns Hopkins where he was a critical care researcher in 2001, Dr. Pronovost developed a simple tool for doctors, a checklist that had never existed before, to remind doctors of each necessary step in performing routine procedures. By following this checklist, the medical errors that lead to infections were drastically reduced. Dr. Pronovost's published research resulted in the medical community becoming much more aware of the causes of and the need for infection prevention and control, and saved many lives through the wonderfully simple but necessary checklist.

"I'm excited to be joining the Board of Cantel Medical, a company I believe is as passionate and dedicated to infection prevention and control as I am," stated Dr. Pronovost. "I look forward to working with Cantel Medical to further advance the science and awareness in the future."

About Cantel Medical Corp.

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for the dental industry, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
2. Kinetic Systems Appoints Peter M. Maris President & Chief Executive Officer
3. Chula Vistas Dr. Peter Rullan Adds Alma Lasers Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients
4. Accuray Appoints Peter Fine to Board of Directors
5. Codexis Names Peter Strumph SVP, Commercial Operations
6. Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
7. Vermillion Adds Peter S. Roddy to Board and Provides Corporate Update
8. Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing
9. VIVUS Announces Promotion of Peter Tam to President
10. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
11. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... 2017  New York City-based market research firm Kalorama Information ... aware of.  From new products to new costs, to the ... recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact Moment Arriving ... the impact the growing population and, to a more extreme ...
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... The Margarian Law Firm has filed a class ... ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ... Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is made ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to ... shoes,” says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To ... Kickstarter on Monday, July 21st. , The kit uses colorful, engaging and educational ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... torn anterior cruciate ligament (ACL) offer patients improved quality of life five years ... for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The study followed ...
(Date:7/20/2017)... Boston, MA (PRWEB) , ... July 20, 2017 ... ... aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. ... often recommended to reduce the chance of reoccurrence and relapse. With such ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... in which their iMedSecure™ comes included with each system installation. RMT’s iMedHD2™ ... to remote participants for real-time collaboration and immediate decision-making requirements. While never ...
Breaking Medicine News(10 mins):